NexgenRX Inc. (NXG) — Cash Flow-to-Debt Ratio
NexgenRX Inc. (NXG) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CA$880.82K could theoretically repay 0% of its total liabilities (CA$30.91 Million) in one year. Explore how much of NexgenRX Inc.'s assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NexgenRX Inc. Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for NexgenRX Inc. across 12 annual periods. Also explore how large is NexgenRX Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for NexgenRX Inc. (2013–2024)
Year-by-year debt coverage analysis for NexgenRX Inc.. For market capitalisation and broader financial context, see NexgenRX Inc. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | CA$1.15 Million | CA$22.84 Million | ▼ -11.4% |
| 2023 | 0.06x | CA$1.28 Million | CA$22.48 Million | ▼ -10.0% |
| 2022 | 0.06x | CA$1.07 Million | CA$16.90 Million | ▼ -67.5% |
| 2021 | 0.19x | CA$3.82 Million | CA$19.72 Million | ▲ +44.2% |
| 2020 | 0.13x | CA$2.65 Million | CA$19.72 Million | ▲ +148.9% |
| 2019 | 0.05x | CA$1.05 Million | CA$19.35 Million | ▲ +271.1% |
| 2018 | -0.03x | CA$-507.38K | CA$16.07 Million | ▲ +5.4% |
| 2017 | -0.03x | CA$-257.35K | CA$7.71 Million | ▼ -150.5% |
| 2016 | 0.07x | CA$490.96K | CA$7.43 Million | ▲ +1357.2% |
| 2015 | -0.01x | CA$-34.94K | CA$6.64 Million | ▲ +98.9% |
| 2014 | -0.47x | CA$-558.18K | CA$1.18 Million | ▼ -183.8% |
| 2013 | 0.56x | CA$774.08K | CA$1.37 Million | — |